TipRanks
Go Ultimate55% OFF

Inhibitor Therapeutics (INTI) Income Statement

Inhibitor Therapeutics Income Statement

Last quarter (Q2 2026), Inhibitor Therapeutics's total revenue was $0.00. In Q2, Inhibitor Therapeutics's net income was $-613.93K. See Inhibitor Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ 3.43M$ 3.66M$ 3.40M$ 657.93K$ 325.39K
Depreciation and Amortization$ 0.00$ 3.66M$ 3.40M$ 657.93K$ 325.39K
$ -3.43M$ 318.41K$ 378.98K$ -74.00$ -130.60K
$ -3.43M$ -3.66M$ -3.40M$ -658.00K$ -325.00K
$ 126.32K$ 318.21K$ 378.84K$ 12.82M$ 26.76K
$ -3.30M$ -3.34M$ -3.03M$ 12.16M$ -299.00K
$ -3.30M$ -3.34M$ -3.03M$ 12.11M$ -299.00K
Per Share Metrics
Basic EPS$ -0.02$ -0.02$ -0.02$ 0.03$ -0.00
Diluted EPS$ -0.02$ -0.02$ -0.02$ 0.03$ -0.00
Weighted Average Shares Outstanding172.51M172.26M151.31M366.18M376.25M
Weighted Average Shares Outstanding (Diluted)172.51M172.26M171.95M367.78M376.25M

Currency in USD

Inhibitor Therapeutics Earnings and Revenue History

-8M08M16M0 %0.4 %0.8 %1.2 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin